Hyperopic Smile-Pro: One-Year Outcomes As Compared To Femtolasik
Published 2026 - 44th Congress of the ESCRS
Reference: POREF099 | Type: Free paper | DOI: 10.82333/0tw0-wf58
Authors: Dr Ahmed Shabana* 1
1Ophthalmology ,Al zahra hospital,Dubai,United Arab Emirates
Purpose
To report one-year visual and refractive outcomes of hyperopic SMILE-PRO from one of the first centers worldwide to perform this procedure and to compare its performance with femtosecond LASIK for hyperopia correction. Hyperopic corneal refractive surgery remains challenging due to regression, optical quality limitations, and biomechanical effects. This study evaluates whether SMILE-PRO provides superior predictability, stability, and quality of vision.
Setting
Single tertiary refractive surgery center in Dubai, United Arab Emirates, among the earliest global adopters of hyperopic SMILE-PRO. All procedures were performed by one experienced refractive surgeon using standardized surgical protocols and follow-up assessments.
Methods
Prospective analysis of hyperopic patients undergoing SMILE-PRO with one-year follow-up. Outcomes included uncorrected and corrected distance visual acuity, refractive predictability, stability, enhancement rates, higher-order aberrations, contrast sensitivity, and patient-reported quality of vision. Results were compared with a matched cohort of hyperopic femtosecond LASIK patients treated during the same period.
Results
SMILE-PRO demonstrated high refractive accuracy and stability at one year, with the majority of eyes within ±0.50 D of target. Compared with femtosecond LASIK, SMILE-PRO showed lower induction of higher-order aberrations, better contrast sensitivity, and reduced dry eye symptoms. Regression rates and enhancement requirements were lower in the SMILE-PRO group. Patient satisfaction and spectacle independence were high.
Conclusions
Hyperopic SMILE-PRO provides predictable and stable refractive outcomes with superior optical quality compared with femtosecond LASIK. The flapless approach may preserve corneal biomechanics and reduce postoperative dry eye, addressing key limitations of hyperopic LASIK. These early one-year results support SMILE-PRO as a promising advancement in hyperopia correction.